Director sold ~$67K of Teradyne
Scheduled in advanceLoading…
Planned for Sep 15, 2026 · Notice filed Sep 15, 2026
A board member of Teradyne told the SEC they plan to sell $270K of Teradyne shares around Sep 15, 2026. The shares came from their pay, which is the usual reason to sell.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
None found in footnotes
Only flagged when a footnote says so; never inferred
Director sold ~$67K of Teradyne
Scheduled in advanceDirector plans to sell ~$67K of Teradyne
Planned, from payNot classified as an open-market trade.